RecruitingNCT04421326
Multimodal Investigation of Intracranial Clot Environment
Sponsor
University Hospital, Montpellier
Enrollment
200 participants
Start Date
Mar 14, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
Analysis of peri clot blood collected at the acute phase of stroke in order to understand physiopathological mechanisms involved in the cerebrovascular damage
Eligibility
Min Age: 18 YearsMax Age: 100 Years
Inclusion Criteria3
- Over 18 years of age,
- Non-dependent for activities of daily living prior to the onset of the MI (Modified Rankin Score >2)
- Having an occlusion of a large arterial trunk proven by imaging (angio-MRI or angio-scanner).
Exclusion Criteria2
- Patients initially admitted but for whom endovascular treatment will not finally be performed (re-infusion, catheterization failure...) will be excluded from the study.
- Major patients under guardianship or curatorship or patients deprived of liberty
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERAnalysis of the clot
Blood sampling at the site of intracranial occlusion during Mechanical Thrombectomy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04421326
Related Trials
CUHK Brain Health Longitudinal Study
NCT035925632 locations
Impact of COVID-19 Vaccines on Cerebrovascular Health
NCT049921951 location
Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
NCT069546101 location
Anesthesia Techniques, Neuroprotection and Surgical Field in FESS Under Controlled Hypotension
NCT071815641 location
PRecisiOn Medicine In StrokE: Evolution of Plasma Brain-Derived Tau in Acute Stroke
NCT061213361 location